Global Nucleic Acid Blood Screening Market Research Report 2026(Status and Outlook)
Description
Report Overview
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nucleic Acid Blood Screening competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Nucleic acid blood screening is a blood safety detection method based on molecular biology technology. Its core lies in the early diagnosis and risk elimination of viral, bacterial and other pathogen infections by specifically amplifying and detecting the nucleic acid sequences (DNA or RNA) of pathogens in blood samples. This technology uses nucleic acid amplification detection (NAT) platforms (such as real-time fluorescence quantitative PCR, transcription-mediated amplification, etc.) to identify extremely low concentrations of pathogen nucleic acids in the blood with high sensitivity and specificity. It is particularly suitable for screening samples in the ""window period"" of infection that cannot be covered by traditional serological tests, thereby significantly reducing the risk of transfusion-transmitted infections (TTIs) and ensuring the safety of clinical blood use. Its detection targets include blood-borne disease pathogens such as HBV, HCV, and HIV, and has become a key link in blood quality control in modern transfusion medicine.The current nucleic acid blood screening market is showing a steady growth trend worldwide. The North American market is dominant due to the popularization of nucleic acid detection technology and policy support, while the Asia-Pacific region has become the fastest growing region due to its aging population, increased medical expenditures and improved infrastructure. On the technical level, NAT (nucleic acid amplification detection) occupies the largest market share, and its high sensitivity drives the demand of end users such as blood banks and hospitals. Emerging economies such as India, the Middle East and Africa show high growth potential due to increased medical spending and disposable income, but challenges such as high technology costs and shortage of skilled personnel still restrict market development. In the future, with the iteration of testing technology and the increasing global attention to blood safety, the market is expected to usher in opportunities for continued expansion.
The global Nucleic Acid Blood Screening market size was estimated at USD 4434.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Acid Blood Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Acid Blood Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acid Blood Screening market.
Global Nucleic Acid Blood Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Grifols Diagnostic Solutions
KHB
Bacme Bio
Daan Gene
Wantai Biotechnology
Sansure Biotech
Zhuhai Livzon Reagents
Bio-Rad Laboratories
Horiba
Thermo Fisher Scientific
bioMerieux
Danaher
Abbott
BD
Mindray
Market Segmentation (by Type)
Blood Screening Equipment
blood Screening Reagents
Market Segmentation (by Application)
Blood Center
Central Blood Station
Central Blood Bank
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nucleic Acid Blood Screening Market
Overview of the regional outlook of the Nucleic Acid Blood Screening Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid Blood Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid Blood Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nucleic Acid Blood Screening competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Nucleic acid blood screening is a blood safety detection method based on molecular biology technology. Its core lies in the early diagnosis and risk elimination of viral, bacterial and other pathogen infections by specifically amplifying and detecting the nucleic acid sequences (DNA or RNA) of pathogens in blood samples. This technology uses nucleic acid amplification detection (NAT) platforms (such as real-time fluorescence quantitative PCR, transcription-mediated amplification, etc.) to identify extremely low concentrations of pathogen nucleic acids in the blood with high sensitivity and specificity. It is particularly suitable for screening samples in the ""window period"" of infection that cannot be covered by traditional serological tests, thereby significantly reducing the risk of transfusion-transmitted infections (TTIs) and ensuring the safety of clinical blood use. Its detection targets include blood-borne disease pathogens such as HBV, HCV, and HIV, and has become a key link in blood quality control in modern transfusion medicine.The current nucleic acid blood screening market is showing a steady growth trend worldwide. The North American market is dominant due to the popularization of nucleic acid detection technology and policy support, while the Asia-Pacific region has become the fastest growing region due to its aging population, increased medical expenditures and improved infrastructure. On the technical level, NAT (nucleic acid amplification detection) occupies the largest market share, and its high sensitivity drives the demand of end users such as blood banks and hospitals. Emerging economies such as India, the Middle East and Africa show high growth potential due to increased medical spending and disposable income, but challenges such as high technology costs and shortage of skilled personnel still restrict market development. In the future, with the iteration of testing technology and the increasing global attention to blood safety, the market is expected to usher in opportunities for continued expansion.
The global Nucleic Acid Blood Screening market size was estimated at USD 4434.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nucleic Acid Blood Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nucleic Acid Blood Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acid Blood Screening market.
Global Nucleic Acid Blood Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Grifols Diagnostic Solutions
KHB
Bacme Bio
Daan Gene
Wantai Biotechnology
Sansure Biotech
Zhuhai Livzon Reagents
Bio-Rad Laboratories
Horiba
Thermo Fisher Scientific
bioMerieux
Danaher
Abbott
BD
Mindray
Market Segmentation (by Type)
Blood Screening Equipment
blood Screening Reagents
Market Segmentation (by Application)
Blood Center
Central Blood Station
Central Blood Bank
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nucleic Acid Blood Screening Market
Overview of the regional outlook of the Nucleic Acid Blood Screening Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid Blood Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid Blood Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
158 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Nucleic Acid Blood Screening
- 1.2 Key Market Segments
- 1.2.1 Nucleic Acid Blood Screening Segment by Type
- 1.2.2 Nucleic Acid Blood Screening Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Nucleic Acid Blood Screening Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Nucleic Acid Blood Screening Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Nucleic Acid Blood Screening Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Nucleic Acid Blood Screening Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Nucleic Acid Blood Screening Product Life Cycle
- 3.3 Global Nucleic Acid Blood Screening Sales by Manufacturers (2020-2025)
- 3.4 Global Nucleic Acid Blood Screening Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Nucleic Acid Blood Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Nucleic Acid Blood Screening Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Nucleic Acid Blood Screening Market Competitive Situation and Trends
- 3.8.1 Nucleic Acid Blood Screening Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Nucleic Acid Blood Screening Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Nucleic Acid Blood Screening Industry Chain Analysis
- 4.1 Nucleic Acid Blood Screening Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Nucleic Acid Blood Screening Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Nucleic Acid Blood Screening Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Nucleic Acid Blood Screening Market
- 5.7 ESG Ratings of Leading Companies
- 6 Nucleic Acid Blood Screening Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Nucleic Acid Blood Screening Sales Market Share by Type (2020-2025)
- 6.3 Global Nucleic Acid Blood Screening Market Size by Type (2020-2025)
- 6.4 Global Nucleic Acid Blood Screening Price by Type (2020-2025)
- 7 Nucleic Acid Blood Screening Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Nucleic Acid Blood Screening Market Sales by Application (2020-2025)
- 7.3 Global Nucleic Acid Blood Screening Market Size (M USD) by Application (2020-2025)
- 7.4 Global Nucleic Acid Blood Screening Sales Growth Rate by Application (2020-2025)
- 8 Nucleic Acid Blood Screening Market Sales by Region
- 8.1 Global Nucleic Acid Blood Screening Sales by Region
- 8.1.1 Global Nucleic Acid Blood Screening Sales by Region
- 8.1.2 Global Nucleic Acid Blood Screening Sales Market Share by Region
- 8.2 Global Nucleic Acid Blood Screening Market Size by Region
- 8.2.1 Global Nucleic Acid Blood Screening Market Size by Region
- 8.2.2 Global Nucleic Acid Blood Screening Market Size by Region
- 8.3 North America
- 8.3.1 North America Nucleic Acid Blood Screening Sales by Country
- 8.3.2 North America Nucleic Acid Blood Screening Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Nucleic Acid Blood Screening Sales by Country
- 8.4.2 Europe Nucleic Acid Blood Screening Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Nucleic Acid Blood Screening Sales by Region
- 8.5.2 Asia Pacific Nucleic Acid Blood Screening Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Nucleic Acid Blood Screening Sales by Country
- 8.6.2 South America Nucleic Acid Blood Screening Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Nucleic Acid Blood Screening Sales by Region
- 8.7.2 Middle East and Africa Nucleic Acid Blood Screening Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Nucleic Acid Blood Screening Market Production by Region
- 9.1 Global Production of Nucleic Acid Blood Screening by Region(2020-2025)
- 9.2 Global Nucleic Acid Blood Screening Revenue Market Share by Region (2020-2025)
- 9.3 Global Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Nucleic Acid Blood Screening Production
- 9.4.1 North America Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
- 9.4.2 North America Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Nucleic Acid Blood Screening Production
- 9.5.1 Europe Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
- 9.5.2 Europe Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Nucleic Acid Blood Screening Production (2020-2025)
- 9.6.1 Japan Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
- 9.6.2 Japan Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Nucleic Acid Blood Screening Production (2020-2025)
- 9.7.1 China Nucleic Acid Blood Screening Production Growth Rate (2020-2025)
- 9.7.2 China Nucleic Acid Blood Screening Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Roche
- 10.1.1 Roche Basic Information
- 10.1.2 Roche Nucleic Acid Blood Screening Product Overview
- 10.1.3 Roche Nucleic Acid Blood Screening Product Market Performance
- 10.1.4 Roche Business Overview
- 10.1.5 Roche SWOT Analysis
- 10.1.6 Roche Recent Developments
- 10.2 Grifols Diagnostic Solutions
- 10.2.1 Grifols Diagnostic Solutions Basic Information
- 10.2.2 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Overview
- 10.2.3 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Market Performance
- 10.2.4 Grifols Diagnostic Solutions Business Overview
- 10.2.5 Grifols Diagnostic Solutions SWOT Analysis
- 10.2.6 Grifols Diagnostic Solutions Recent Developments
- 10.3 KHB
- 10.3.1 KHB Basic Information
- 10.3.2 KHB Nucleic Acid Blood Screening Product Overview
- 10.3.3 KHB Nucleic Acid Blood Screening Product Market Performance
- 10.3.4 KHB Business Overview
- 10.3.5 KHB SWOT Analysis
- 10.3.6 KHB Recent Developments
- 10.4 Bacme Bio
- 10.4.1 Bacme Bio Basic Information
- 10.4.2 Bacme Bio Nucleic Acid Blood Screening Product Overview
- 10.4.3 Bacme Bio Nucleic Acid Blood Screening Product Market Performance
- 10.4.4 Bacme Bio Business Overview
- 10.4.5 Bacme Bio Recent Developments
- 10.5 Daan Gene
- 10.5.1 Daan Gene Basic Information
- 10.5.2 Daan Gene Nucleic Acid Blood Screening Product Overview
- 10.5.3 Daan Gene Nucleic Acid Blood Screening Product Market Performance
- 10.5.4 Daan Gene Business Overview
- 10.5.5 Daan Gene Recent Developments
- 10.6 Wantai Biotechnology
- 10.6.1 Wantai Biotechnology Basic Information
- 10.6.2 Wantai Biotechnology Nucleic Acid Blood Screening Product Overview
- 10.6.3 Wantai Biotechnology Nucleic Acid Blood Screening Product Market Performance
- 10.6.4 Wantai Biotechnology Business Overview
- 10.6.5 Wantai Biotechnology Recent Developments
- 10.7 Sansure Biotech
- 10.7.1 Sansure Biotech Basic Information
- 10.7.2 Sansure Biotech Nucleic Acid Blood Screening Product Overview
- 10.7.3 Sansure Biotech Nucleic Acid Blood Screening Product Market Performance
- 10.7.4 Sansure Biotech Business Overview
- 10.7.5 Sansure Biotech Recent Developments
- 10.8 Zhuhai Livzon Reagents
- 10.8.1 Zhuhai Livzon Reagents Basic Information
- 10.8.2 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Overview
- 10.8.3 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Market Performance
- 10.8.4 Zhuhai Livzon Reagents Business Overview
- 10.8.5 Zhuhai Livzon Reagents Recent Developments
- 10.9 Bio-Rad Laboratories
- 10.9.1 Bio-Rad Laboratories Basic Information
- 10.9.2 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Overview
- 10.9.3 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Market Performance
- 10.9.4 Bio-Rad Laboratories Business Overview
- 10.9.5 Bio-Rad Laboratories Recent Developments
- 10.10 Horiba
- 10.10.1 Horiba Basic Information
- 10.10.2 Horiba Nucleic Acid Blood Screening Product Overview
- 10.10.3 Horiba Nucleic Acid Blood Screening Product Market Performance
- 10.10.4 Horiba Business Overview
- 10.10.5 Horiba Recent Developments
- 10.11 Thermo Fisher Scientific
- 10.11.1 Thermo Fisher Scientific Basic Information
- 10.11.2 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Overview
- 10.11.3 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Market Performance
- 10.11.4 Thermo Fisher Scientific Business Overview
- 10.11.5 Thermo Fisher Scientific Recent Developments
- 10.12 bioMerieux
- 10.12.1 bioMerieux Basic Information
- 10.12.2 bioMerieux Nucleic Acid Blood Screening Product Overview
- 10.12.3 bioMerieux Nucleic Acid Blood Screening Product Market Performance
- 10.12.4 bioMerieux Business Overview
- 10.12.5 bioMerieux Recent Developments
- 10.13 Danaher
- 10.13.1 Danaher Basic Information
- 10.13.2 Danaher Nucleic Acid Blood Screening Product Overview
- 10.13.3 Danaher Nucleic Acid Blood Screening Product Market Performance
- 10.13.4 Danaher Business Overview
- 10.13.5 Danaher Recent Developments
- 10.14 Abbott
- 10.14.1 Abbott Basic Information
- 10.14.2 Abbott Nucleic Acid Blood Screening Product Overview
- 10.14.3 Abbott Nucleic Acid Blood Screening Product Market Performance
- 10.14.4 Abbott Business Overview
- 10.14.5 Abbott Recent Developments
- 10.15 BD
- 10.15.1 BD Basic Information
- 10.15.2 BD Nucleic Acid Blood Screening Product Overview
- 10.15.3 BD Nucleic Acid Blood Screening Product Market Performance
- 10.15.4 BD Business Overview
- 10.15.5 BD Recent Developments
- 10.16 Mindray
- 10.16.1 Mindray Basic Information
- 10.16.2 Mindray Nucleic Acid Blood Screening Product Overview
- 10.16.3 Mindray Nucleic Acid Blood Screening Product Market Performance
- 10.16.4 Mindray Business Overview
- 10.16.5 Mindray Recent Developments
- 11 Nucleic Acid Blood Screening Market Forecast by Region
- 11.1 Global Nucleic Acid Blood Screening Market Size Forecast
- 11.2 Global Nucleic Acid Blood Screening Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Nucleic Acid Blood Screening Market Size Forecast by Country
- 11.2.3 Asia Pacific Nucleic Acid Blood Screening Market Size Forecast by Region
- 11.2.4 South America Nucleic Acid Blood Screening Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Nucleic Acid Blood Screening by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Nucleic Acid Blood Screening Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Nucleic Acid Blood Screening by Type (2026-2035)
- 12.1.2 Global Nucleic Acid Blood Screening Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Nucleic Acid Blood Screening by Type (2026-2035)
- 12.2 Global Nucleic Acid Blood Screening Market Forecast by Application (2026-2035)
- 12.2.1 Global Nucleic Acid Blood Screening Sales (K Units) Forecast by Application
- 12.2.2 Global Nucleic Acid Blood Screening Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
